There are very few reports and limited evidence that premedication with steroids decreases early recurrence of ileocolic intussusception after a successful hydrostatic reduction. The purpose of this study was to examine the role of steroids in decreasing early recurrence of idiopathic intussusceptions. A retrospective review of children that underwent successful hydrostatic reduction was conducted. Two groups were identified: group 1 (38 cases) that received intravenous methylprednisolone (1 mg/kg/dose) on diagnosis or immediately after the reduction maneuver, and group 2 (59 cases) were not given. There were 60 boys and 37 girls ranging in age from 6 to 84 months. There were no statistical differences between the groups regarding age, sex, duration of symptoms and laboratory findings on admission. There was no significant difference (p=0.76) in the rate of early recurrent intussusception between the steroid group (15.8%, 6/38) and the non-steroid group (13.6%, 8/59). We found that premedication of children with idiopathic intussusception with methylprednisolone did not decrease early recurrence of idiopathic intussusceptions.
The intussusception recurs in approximately 10 percent of children after successful nonoperative reduction. The main objective was to determine the clinical and sonographic findings that could be used to predict recurrence of ileocolic intussusception in children that had been successfully reduced by enema. A retrospective search was performed on 66 children, at age of 3 months to 7 years, with successful enema reduction of intussusception during a 2.5-year period from January 2013 to July 2015. The clinical, laboratory records, and sonographic findings were compared between recurrence of intussusceptions group (ROI) and non-recurrence group (NROI). Statistical significances were found in age (median, 26.0 vs 18.5 months; P =0.022) and terminal ileal wall thickening (mean, 10.23 vs 7.8 mm; p=0.002); in contrast, there was no significance considering gender, irritability (p=0.074), currant jelly stool (p=1.0), or C-reactive protein (p=0.908). Recurrence is associated with age and the thickening of terminal ileal wall, but clinical or laboratory findings. Given the small number of cases, further studies should be conducted.
Intussusception in adults is a rare disease entity; its clinical course and etiology are different from its pediatric counterpart. Furthermore, intussusception caused by intestinal tuberculosis is very rare. We report on a case of transient intussusception induced by intestinal tuberculosis. A 29-year-old female visited our hospital with a chief complaint of right lower quadrant abdominal pain. Abdominal computed tomography showed ileo-colic type intussusception. Intussusception was transient and showed spontaneous reduction. Colonoscopy was performed for evaluation of the cause and intestinal tuberculosis was probable on colonoscopic biopsy. Follow up colonoscopy showed improvement after administration of anti-tuberculosis medication and intestinal tuberculosis was then confirmed.
장중첩증은 2세 이하의 소아, 특히 남자 환아의 장폐쇄를 일으키는 가장 흔한 질환이다. 이에 저자들 은 2005년 6월 1일부터 2007년 5월 31일까지 만 2년 동안 응급실로 내원하여 소아 복부 초음파를 통해 장중첩증으로 진단을 받고 비수술적 정복술을 시행한 환아 54명에 대해 임상 분석하여 다음과 같은 결 과를 얻었다. 1) 연령별 분포는 13~24개월 사이가 40.7%였고, 성별분포는 남아가 72.2%, 여아가 27.8%로 남녀의 비는 2.6:1이었다. 2) 임상증상은 복통 및 보챔(100.0%), 구토(66.7%), 설사(33.3%)등 이었고, 설사증상을 나타낸 환아에 서 장중첩증 정복성공이 유의하게 감소하였다(p<0.05). 혈액상 특성으로 백혈구수는 10,000~15,000개 사이가 29.6%였다. 3) 개인병원의 1차 진료 후 본원에 내원한 환아는 42.6%였고, 증상발현에서 처치까지의 소요시간은 6~12시간이 37.0%로 많았다. 4) 장중첩증의 유형은 회장-결장형이 98.1%였고, 장중첩증의 위치는 간만곡부가 68.5%였다. 5) 공기압정복술의 성공률은 88.0%였고, 바륨정복술은 86.2%였다(p>0.05).